Your browser doesn't support javascript.
loading
The immune landscape of undifferentiated pleomorphic sarcoma.
Lazcano, Rossana; Barreto, Carmelia M; Salazar, Ruth; Carapeto, Fernando; Traweek, Raymond S; Leung, Cheuk H; Gite, Swati; Mehta, Jay; Ingram, Davis R; Wani, Khalida M; Vu, Kim-Anh T; Parra, Edwin R; Lu, Wei; Zhou, Jianling; Witt, Russell G; Cope, Brandon; Thirasastr, Prapassorn; Lin, Heather Y; Scally, Christopher P; Conley, Anthony P; Ratan, Ravin; Livingston, J Andrew; Zarzour, Alexandra M; Ludwig, Joseph; Araujo, Dejka; Ravi, Vinod; Patel, Shreyaskumar; Benjamin, Robert; Wargo, Jennifer; Wistuba, Ignacio I; Somaiah, Neeta; Roland, Christina L; Keung, Emily Z; Solis, Luisa; Wang, Wei-Lien; Lazar, Alexander J; Nassif, Elise F.
Affiliation
  • Lazcano R; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Barreto CM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Salazar R; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Carapeto F; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Traweek RS; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Leung CH; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Gite S; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Mehta J; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ingram DR; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wani KM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Vu KT; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Parra ER; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Lu W; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Zhou J; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Witt RG; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Cope B; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Thirasastr P; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Lin HY; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Scally CP; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Conley AP; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ratan R; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Livingston JA; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Zarzour AM; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ludwig J; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Araujo D; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ravi V; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Patel S; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Benjamin R; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wargo J; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wistuba II; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Somaiah N; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Roland CL; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.
  • Keung EZ; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Solis L; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wang WL; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Lazar AJ; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Nassif EF; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.
Front Oncol ; 12: 1008484, 2022.
Article in En | MEDLINE | ID: mdl-36313661
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication: